FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1971508775> ?p ?o ?g. }

• W1971508775 endingPage "1185" @default.
• W1971508775 startingPage "1177" @default.
• W1971508775 abstract "Dexpramipexole (KNS-760704; [6R]-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine) is a novel synthetic amino-benzothiazole in development for the treatment of amyotrophic lateral sclerosis (ALS). Preclinical studies have shown that dexpramipexole is neuroprotective in vitro and in vivo, is highly orally bioavailable and water soluble, and rapidly achieves and maintains high central nervous system concentrations relative to plasma. Two phase 1 clinical studies were conducted to assess the safety, tolerability, and pharmacokinetics (PK) of single and multiple doses of dexpramipexole in 54 healthy male and female adults. The effect of food on the single-dose PK of dexpramipexole was also evaluated. Single doses (50 mg, 150 mg, or 300 mg) and multiple doses (50 mg twice daily, 100 mg twice daily, or 150 mg twice daily) of dexpramipexole over 4.5 days were safe and well tolerated. Dexpramipexole was rapidly absorbed, with time to maximum plasma concentration ranging from 1.8 to 2.6 hours and half-life ranging from 6.4 to 8.1 hours under fasted conditions, and was mostly eliminated in urine as unchanged parent drug (84%–90% of dose). Food had no effect on the single-dose PK of dexpramipexole. These findings support the ongoing development of dexpramipexole for the treatment of ALS and further evaluation of the compound's therapeutic potential in other neurodegenerative diseases." @default.
• W1971508775 created "2016-06-24" @default.
• W1971508775 creator A5008615465 @default.
• W1971508775 creator A5027362558 @default.
• W1971508775 creator A5034011229 @default.
• W1971508775 creator A5071076502 @default.
• W1971508775 creator A5075818401 @default.
• W1971508775 date "2011-08-01" @default.
• W1971508775 modified "2023-09-30" @default.
• W1971508775 title "Safety, Tolerability, and Pharmacokinetics of KNS-760704 (Dexpramipexole) in Healthy Adult Subjects" @default.
• W1971508775 cites W1843400861 @default.
• W1971508775 cites W1970276218 @default.
• W1971508775 cites W1976883261 @default.
• W1971508775 cites W1978406998 @default.
• W1971508775 cites W1998970893 @default.
• W1971508775 cites W2000950988 @default.
• W1971508775 cites W2017727562 @default.
• W1971508775 cites W2027125601 @default.
• W1971508775 cites W2033158384 @default.
• W1971508775 cites W2044395254 @default.
• W1971508775 cites W2046684326 @default.
• W1971508775 cites W2048149415 @default.
• W1971508775 cites W2048606094 @default.
• W1971508775 cites W2063641455 @default.
• W1971508775 cites W2068800657 @default.
• W1971508775 cites W2071362963 @default.
• W1971508775 cites W2087541485 @default.
• W1971508775 cites W2106771669 @default.
• W1971508775 cites W2107197030 @default.
• W1971508775 cites W2110310280 @default.
• W1971508775 cites W2110382075 @default.
• W1971508775 cites W2111377404 @default.
• W1971508775 cites W2135843341 @default.
• W1971508775 cites W2144372673 @default.
• W1971508775 cites W2156039741 @default.
• W1971508775 cites W2156252190 @default.
• W1971508775 cites W2162616806 @default.
• W1971508775 cites W2165370634 @default.
• W1971508775 cites W4236884331 @default.
• W1971508775 cites W4238441185 @default.
• W1971508775 cites W4244605837 @default.
• W1971508775 cites W4246407538 @default.
• W1971508775 cites W4252533768 @default.
• W1971508775 cites W4295135156 @default.
• W1971508775 doi "https://doi.org/10.1177/0091270010379412" @default.
• W1971508775 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20959524" @default.
• W1971508775 hasPublicationYear "2011" @default.
• W1971508775 type Work @default.
• W1971508775 sameAs 1971508775 @default.
• W1971508775 citedByCount "37" @default.
• W1971508775 countsByYear W19715087752012 @default.
• W1971508775 countsByYear W19715087752014 @default.
• W1971508775 countsByYear W19715087752015 @default.
• W1971508775 countsByYear W19715087752016 @default.
• W1971508775 countsByYear W19715087752017 @default.
• W1971508775 countsByYear W19715087752018 @default.
• W1971508775 countsByYear W19715087752019 @default.
• W1971508775 countsByYear W19715087752020 @default.
• W1971508775 countsByYear W19715087752021 @default.
• W1971508775 countsByYear W19715087752022 @default.
• W1971508775 countsByYear W19715087752023 @default.
• W1971508775 crossrefType "journal-article" @default.
• W1971508775 hasAuthorship W1971508775A5008615465 @default.
• W1971508775 hasAuthorship W1971508775A5027362558 @default.
• W1971508775 hasAuthorship W1971508775A5034011229 @default.
• W1971508775 hasAuthorship W1971508775A5071076502 @default.
• W1971508775 hasAuthorship W1971508775A5075818401 @default.
• W1971508775 hasConcept C112705442 @default.
• W1971508775 hasConcept C150903083 @default.
• W1971508775 hasConcept C178790620 @default.
• W1971508775 hasConcept C181389837 @default.
• W1971508775 hasConcept C185592680 @default.
• W1971508775 hasConcept C197934379 @default.
• W1971508775 hasConcept C207001950 @default.
• W1971508775 hasConcept C25498285 @default.
• W1971508775 hasConcept C2777456753 @default.
• W1971508775 hasConcept C2778375690 @default.
• W1971508775 hasConcept C71924100 @default.
• W1971508775 hasConcept C86803240 @default.
• W1971508775 hasConcept C98274493 @default.
• W1971508775 hasConceptScore W1971508775C112705442 @default.
• W1971508775 hasConceptScore W1971508775C150903083 @default.
• W1971508775 hasConceptScore W1971508775C178790620 @default.
• W1971508775 hasConceptScore W1971508775C181389837 @default.
• W1971508775 hasConceptScore W1971508775C185592680 @default.
• W1971508775 hasConceptScore W1971508775C197934379 @default.
• W1971508775 hasConceptScore W1971508775C207001950 @default.
• W1971508775 hasConceptScore W1971508775C25498285 @default.
• W1971508775 hasConceptScore W1971508775C2777456753 @default.
• W1971508775 hasConceptScore W1971508775C2778375690 @default.
• W1971508775 hasConceptScore W1971508775C71924100 @default.
• W1971508775 hasConceptScore W1971508775C86803240 @default.
• W1971508775 hasConceptScore W1971508775C98274493 @default.
• W1971508775 hasIssue "8" @default.
• W1971508775 hasLocation W19715087751 @default.
• W1971508775 hasLocation W19715087752 @default.
• W1971508775 hasOpenAccess W1971508775 @default.
• W1971508775 hasPrimaryLocation W19715087751 @default.

• next